Modified recombinant human erythropoietin with potentially reduced immunogenicity.
Susantad T, Fuangthong M, Tharakaraman K, Tit-Oon P, Ruchirawat M, Sasisekharan R.
Sci Rep. 2021 Jan 15;11(1):1491.
To find the 2nd edition, type "2nd edition"
Modified recombinant human erythropoietin with potentially reduced immunogenicity.
Susantad T, Fuangthong M, Tharakaraman K, Tit-Oon P, Ruchirawat M, Sasisekharan R.
Sci Rep. 2021 Jan 15;11(1):1491.
Prediction of the binding interface between monoclonal antibody m102.4 and Nipah attachment glycoprotein using structure-guided alanine scanning and computational docking.
Tit-Oon P, Tharakaraman K, Artpradit C, Godavarthi A, Sungkeeree P, Sasisekharan V, Kerdwong J, Miller NL, Mahajan B, Khongmanee A, Ruchirawat M, Sasisekharan R, Fuangthong M.
Sci Rep. 2020 Oct 26;10(1):18256.